Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy.
Echinacea purpurea
alkamides
chicoric acid
oxaliplatin
polyphenols
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
revised:
12
12
2022
received:
13
09
2022
accepted:
13
12
2022
medline:
11
5
2023
pubmed:
30
12
2022
entrez:
29
12
2022
Statut:
ppublish
Résumé
Chemotherapy-induced neuropathy represents the main dose-limiting toxicity of several anticancer drugs, such as oxaliplatin, leading to chronic pain and an impairment of the quality of life. Echinacea purpurea n-hexane extract (EP
Substances chimiques
Oxaliplatin
04ZR38536J
Plant Extracts
0
Antineoplastic Agents
0
Polyunsaturated Alkamides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1911-1923Subventions
Organisme : Regione Toscana
Organisme : Università degli Studi di Firenze
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
André, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., … de Gramont, A. (2009). Improved overall survival with oxaliplatin, fluorouracil, and leucovorin As adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. Journal of Clinical Oncology, 27(19), 3109-3116. https://doi.org/10.1200/JCO.2008.20.6771
Ardjomand-Woelkart, K., Kollroser, M., Magnes, C., Sinner, F., Frye, R., Derendorf, H., … Butterweck, V. (2011). Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats. Planta Medica, 77(16), 1794-1799. https://doi.org/10.1055/s-0030-1271120
Baird, L., & Yamamoto, M. (2020). The molecular mechanisms regulating the keap1-nrf2 pathway. Molecular and Cellular Biology, 40(13), e00099-e00020. https://doi.org/10.1128/MCB.00099-20
Baptista-de-Souza, D., Di Cesare Mannelli, L., Zanardelli, M., Micheli, L., Nunes-de-Souza, R. L., Canto-de-Souza, A., & Ghelardini, C. (2014). Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT2C receptor. European Journal of Pharmacology, 735, 141-149. https://doi.org/10.1016/j.ejphar.2014.04.028
Binns, S. E. (2002). The taxonomy, phytochemistry and biological activity of the genus echinacea (Asteraceae). Ottawa, Canada: National Library of Canada-Bibliothèque nationale du Canada.
Bohlmann, F., & Hoffmann, H. (1983). Further amides from Echinacea purpurea. Phytochemistry, 22(5), 1173-1175. https://doi.org/10.1016/0031-9422(83)80215-5
Brindisi, M., Maramai, S., Gemma, S., Brogi, S., Grillo, A., Di Cesare Mannelli, L., … Butini, S. (2016). Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain. Journal of Medicinal Chemistry, 59(6), 2612-2632. https://doi.org/10.1021/acs.jmedchem.5b01812
Bruni, R., Brighenti, V., Caesar, L. K., Bertelli, D., Cech, N. B., & Pellati, F. (2018). Analytical methods for the study of bioactive compounds from medicinally used echinacea species. Journal of Pharmaceutical and Biomedical Analysis, 160, 443-477. https://doi.org/10.1016/j.jpba.2018.07.044
Caesar, L. K., & Cech, N. B. (2019). Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2. Natural Product Reports, 36(6), 869-888. https://doi.org/10.1039/C9NP00011A
Cavaletti, G., Tredici, G., Petruccioli, M. G., Dondè, E., Tredici, P., Marmiroli, P., … Griffon Etienne, G. (2001). Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. European Journal of Cancer, 37(18), 2457-2463. https://doi.org/10.1016/S0959-8049(01)00300-8
Coyle, D. E. (1998). Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia, 23(1), 75-83.
da Silva, K. A. B., Paszcuk, A. F., Passos, G. F., Silva, E. S., Bento, A. F., Meotti, F. C., & Calixto, J. B. (2011). Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain, 152(8), 1872-1887. https://doi.org/10.1016/j.pain.2011.04.005
David, S., & Cunningham, R. (2019). Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis. Complementary Therapies in Medicine, 44, 18-26. https://doi.org/10.1016/j.ctim.2019.03.011
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., … Bonetti, A. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology, 18(16), 2938-2947. https://doi.org/10.1200/JCO.2000.18.16.2938
Di Cesare Mannelli, L., Zanardelli, M., Failli, P., & Ghelardini, C. (2012). Oxaliplatin-induced neuropathy: Oxidative stress as pathological mechanism. Protective effect of silibinin. The Journal of Pain, 13(3), 276-284. https://doi.org/10.1016/j.jpain.2011.11.009
Di Cesare Mannelli, L., Zanardelli, M., Landini, I., Pacini, A., Ghelardini, C., Mini, E., Bencini, A., Valtancoli, B., & Failli, P. (2016). Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy. Free Radical Biology and Medicine, 93, 67-76. https://doi.org/10.1016/j.freeradbiomed.2016.01.023
Efferth, T., & Koch, E. (2011). Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Current Drug Targets, 12(1), 122-132.
Ernst, E. (Ed.). (2006). The desktop guide to complementary and alternative medicine: An evidence-based approach (2. Aufl). Maryland Heights, Missouri: Mosby.
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006). Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research, 1071(1), 10-23. https://doi.org/10.1016/j.brainres.2005.11.035
Hohmann, J., Rédei, D., Forgo, P., Szabó, P., Freund, T. F., Haller, J., … Benyhe, S. (2011). Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. Phytochemistry, 72(14), 1848-1853. https://doi.org/10.1016/j.phytochem.2011.06.008
Hu, C., & Kitts, D. D. (2000). Studies on the antioxidant activity of echinacea root extract. Journal of Agricultural and Food Chemistry, 48(5), 1466-1472. https://doi.org/10.1021/jf990677+
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., … Malan, T. P. (2003). Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS. Proceedings of the National Academy of Sciences of the United States of America, 100(18), 10529-10533. https://doi.org/10.1073/pnas.1834309100
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., … Malan, T. P. (2005). CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proceedings of the National Academy of Sciences of the United States of America, 102(8), 3093-3098. https://doi.org/10.1073/pnas.0409888102
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes \& Development, 13(1), 76-86. https://doi.org/10.1101/gad.13.1.76
Kannarkat, G., Lasher, E. E., & Schiff, D. (2007). Neurologic complications of chemotherapy agents. Current Opinion in Neurology, 20(6), 719-725. https://doi.org/10.1097/WCO.0b013e3282f1a06e
La Porta, C., Bura, S. A., Aracil-Fernández, A., Manzanares, J., & Maldonado, R. (2013). Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate. Pain, 154(1), 160-174. https://doi.org/10.1016/j.pain.2012.10.009
Leyte-Lugo, M., Todd, D. A., Gulledge, T. V., Juzumaite, M., Carter, F. S., Laster, S. M., & Cech, N. B. (2015). Cytokine-suppressive activity of a hydroxylated alkylamide from echinacea purpurea. Planta Medica Letters, 2(1), e25-e27. https://doi.org/10.1055/s-0035-1557764
Li, W., Sun, Y., van Breemen, R. B., & Fitzloff, J. F. (2004). Evaluation of major caffeic acid derivatives in echinacea purpurea dietary supplements by HPLC with photodiode array detection and electrospray mass spectrometry. Journal of Liquid Chromatography \& Related Technologies, 27(16), 2507-2529. https://doi.org/10.1081/JLC-200028369
Linde, K., Barrett, B., Wölkart, K., Bauer, R., & Melchart, D. (2006). Echinacea for preventing and treating the common cold. The. Cochrane Database of Systematic Reviews, 1, CD000530. https://doi.org/10.1002/14651858.CD000530.pub2
Liu, Q., Hu, Y., Cao, Y., Song, G., Liu, Z., & Liu, X. (2017). Chicoric acid ameliorates lipopolysaccharide-induced oxidative stress via promoting the keap1/nrf2 transcriptional signaling pathway in bv-2 microglial cells and mouse brain. Journal of Agricultural and Food Chemistry, 65(2), 338-347. https://doi.org/10.1021/acs.jafc.6b04873
Liu, Q., Wang, Y., Xiao, C., Wu, W., & Liu, X. (2015). Metabolism of chicoric acid by rat liver microsomes and bioactivity comparisons of chicoric acid and its metabolites. Food \& Function, 6(6), 1928-1935. https://doi.org/10.1039/c5fo00073d
Mackie, K. (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of Experimental Pharmacology, 168, 299-325. https://doi.org/10.1007/3-540-26573-2_10
Maggini, V., De Leo, M., Granchi, C., Tuccinardi, T., Mengoni, A., Gallo, E. R., … Bogani, P. (2019). The influence of Echinacea purpurea leaf microbiota on chicoric acid level. Scientific Reports, 9, 10897. https://doi.org/10.1038/s41598-019-47329-8
Maggini, V., De Leo, M., Mengoni, A., Gallo, E. R., Miceli, E., Reidel, R. V. B., … Bogani, P. (2017). Plant-endophytes interaction influences the secondary metabolism in Echinacea purpurea (L.) Moench: An in vitro model. Scientific Reports, 7(1), 16924. https://doi.org/10.1038/s41598-017-17110-w
Maldonado, R., Baños, J. E., & Cabañero, D. (2016). The endocannabinoid system and neuropathic pain. Pain, 157(Suppl), S23-S32. https://doi.org/10.1097/j.pain.0000000000000428
McGrath, J. C., & Lilley, E. (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): New requirements for publication in BJP. British Journal of Pharmacology, 172(13), 3189-3193. https://doi.org/10.1111/bph.12955
Moerman, D. E. (1998). Native american ethnobotany. Portland, Oregon: Timber Press.
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013). Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies. European Journal of Pharmacology, 716(1-3), 142-157. https://doi.org/10.1016/j.ejphar.2013.01.077
Pellati, F., Benvenuti, S., Magro, L., Melegari, M., & Soragni, F. (2004). Analysis of phenolic compounds and radical scavenging activity of echinacea spp. Journal of Pharmaceutical and Biomedical Analysis, 35(2), 289-301. https://www.academia.edu/15439356/Analysis_of_phenolic_compounds_and_radical_scavenging_activity_of_Echinacea_spp.
Pergolizzi, J. V., van de Laar, M., Langford, R., Mellinghoff, H.-U., Merchante, I. M., Nalamachu, S., … Raffa, R. B. (2012). Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain. Journal of Pain Research, 5, 327-346. https://doi.org/10.2147/JPR.S33112
Politi, M., Menghini, L., Conti, B., Bedini, S., Farina, P., Cioni, P. L., … De Leo, M. (2020). Reconsidering hydrosols as main products of aromatic plants manufactory: The lavandin (Lavandula × intermedia) case study in tuscany. Molecules, 25(9), 2225. https://doi.org/10.3390/molecules25092225
Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., … Maldonado, R. (2008). Interferon-γ is a critical modulator of cb2 cannabinoid receptor signaling during neuropathic pain. The Journal of Neuroscience, 28(46), 12136-12145. https://doi.org/10.1523/JNEUROSCI.3402-08.2008
Raduner, S., Majewska, A., Chen, J.-Z., Xie, X.-Q., Hamon, J., Faller, B., … Gertsch, J. (2006). Alkylamides from echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. The Journal of Biological Chemistry, 281(20), 14192-14206. https://doi.org/10.1074/jbc.M601074200
Rahn, E. J., & Hohmann, A. G. (2009). Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside. Neurotherapeutics, 6(4), 713-737. https://doi.org/10.1016/j.nurt.2009.08.002
Reagan-Shaw, S., Nihal, M., & Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB Journal, 22(3), 659-661. https://doi.org/10.1096/fj.07-9574LSF
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology \& Medicine, 20(7), 933-956. https://doi.org/10.1016/0891-5849(95)02227-9
See, D. M., Broumand, N., Sahl, L., & Tilles, J. G. (1997). In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology, 35(3), 229-235. https://doi.org/10.1016/s0162-3109(96)00125-7
Shah, S. A., Sander, S., White, C. M., Rinaldi, M., & Coleman, C. I. (2007). Evaluation of echinacea for the prevention and treatment of the common cold: A meta-analysis. The Lancet. Infectious Diseases, 7(7), 473-480. https://doi.org/10.1016/S1473-3099(07)70160-3
Souglakos, J., Mavroudis, D., Kakolyris, S., Kourousis, C., Vardakis, N., Androulakis, N., … Georgoulias, V. (2002). Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: A multicenter phase ii trial. Journal of Clinical Oncology, 20(11), 2651-2657. https://doi.org/10.1200/JCO.2002.08.015
Thygesen, L., Thulin, J., Mortensen, A., Skibsted, L. H., & Molgaard, P. (2007). Antioxidant activity of cichoric acid and alkamides from Echinacea purpurea, alone and in combination. Food Chemistry, 101(1), 74-81. https://doi.org/10.1016/j.foodchem.2005.11.048
Vaughan, C. W., Connor, M., Bagley, E. E., & Christie, M. J. (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Molecular Pharmacology, 57(2), 288-295.
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001). Glial activation: A driving force for pathological pain. Trends in Neurosciences, 24(8), 450-455. https://doi.org/10.1016/s0166-2236(00)01854-3
Woelkart, K., & Bauer, R. (2007). The role of alkamides as an active principle of echinacea. Planta Medica, 73(7), 615-623. https://doi.org/10.1055/s-2007-981531
Woelkart, K., Xu, W., Pei, Y., Makriyannis, A., Picone, R. P., & Bauer, R. (2005). The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Medica, 71(8), 701-705. https://doi.org/10.1055/s-2005-871290
Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008). Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. European Journal of Cancer (Oxford, England: 1990), 44(11), 1507-1515. https://doi.org/10.1016/j.ejca.2008.04.018
Xu, B., Descalzi, G., Ye, H.-R., Zhuo, M., & Wang, Y.-W. (2012). Translational investigation and treatment of neuropathic pain. Molecular Pain, 8, 15. https://doi.org/10.1186/1744-8069-8-15
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018). The keap1-nrf2 system: A thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiological Reviews, 98(3), 1169-1203. https://doi.org/10.1152/physrev.00023.2017
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003). Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. The European Journal of Neuroscience, 17(12), 2750-2754. https://doi.org/10.1046/j.1460-9568.2003.02704.x
Zhang, R.-X., Liu, B., Wang, L., Ren, K., Qiao, J.-T., Berman, B. M., & Lao, L. (2005). Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 118(1-2), 125-136. https://doi.org/10.1016/j.pain.2005.08.001